A potential biomarker of kidney damage identified by proteomics: preliminary findings

References

• AARDEMA, M. J. and MACGREGOR, J. T. 2002, Toxicology and genetic toxicology in the new era of `toxicogenomics': impact of `-omics' technologies. Mutattion Research, 499, 13–25.
   PubMed Web of Science ®Google Scholar
• BANDARA, L. R and KENNEDY, S. 2002, Toxicoproteomics — a new preclinical tool. Drug Discovery Today, 7, 411–418.
   PubMed Web of Science ®Google Scholar
• BANDARA, L. R, KELLY, M. D., LOCK, E. A. and KENNEDY, S. 2003, A correlation between a proteomic evaluation and conventional measurements in the assessment of renal proximal tubular toxicity. Toxicological Sciences, 73, 195–206.
   PubMed Web of Science ®Google Scholar
• CALDER, I. C., YOUNG, A. C., WOODS, R A., CROWE, C. A., HAM, K N. and TANGE, J. D. 1979, The nephrotoxicity of 4-aminophenol. II. The effect of metabolic inhibitors and inducers. Chemico-biological interactions, 27, 245–254.
   PubMed Web of Science ®Google Scholar
• CHARLWOOD, J., SKEHEL, M., KING, N., CAMILLERI, P., LORD, P., BUGELSKI, P. and ATIF, U. 2002, Proteomic analysis of rat kidney cortex following treatment with gentamicin. Journal of Protecmie Research, 1, 73–82.
   PubMed Web of Science ®Google Scholar
• CROWE, C. A., YONG, A. C., CALDER, I. C., HAM, K N. and TANGE, J. D. 1979, The nephrotoxicity of 4-aminophenol. I. The effect on microsomal cytochromes, glutathione and covalent binding in kidney and liver. Chemico-biological interactions, 27, 235–243.
   PubMed Web of Science ®Google Scholar
• CUTLER, P., BELL, D. J., BIRRELL, H. C., CONNELLY, J. C., CONNOR, S. C., HOLMES, E., MITCHELL, B. C., MONTE, S. Y., NEVILLE, B. A., PICKFORD, R., POLI-EY, S., SCHNEIDER, K and SKEHEL, J. M. 1999, An integrated proteomic approach to studying glomerular nephrotoxicity. Electrophoresis, 20, 3647–3658.
   Google Scholar
• DAVIS, J. M., EMSLIE, K R., SWEET, R. S., WALKER, L. L., NAUGHTON, R. J., SKINNER, S. L. and TANGE, J. D. 1983, Early functional and morphological changes in renal tubular necrosis due to 4-aminophenol. Kidney International, 24, 740–747.
   PubMed Web of Science ®Google Scholar
• ECKERT, K G., EYER, P., SONNENBICHLER, J. and ZETL, I. 1990,11. Synthesis and structural elucidation of various thiol addition products of 1,4-benzoquinoneimine and N-acetyl-1,4-benzoquinonei-mine. Xenobiotica, 20, 333–350.
   PubMed Web of Science ®Google Scholar
• ENDO, F., KTJBO, S., AWATA, H., KiwAKI, K, KATOH, H., KANEGAE, Y., SAITO, I., MIYAZAKI, J., YAMAMOTO, T., JAKOBS, C., HATTORI, S. and MATSUDA, I. 1997, Complete rescue of lethal albino cl 4CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway. Journal of Biological Chemistry, 272, 24426–24432.
   PubMed Web of Science ®Google Scholar
• FORGET, S., PATRIQUIN, H. B., DTJBOIS, J., LAFORTTJNE, M., MEROTJANI, A., PARADIS, K. and RTJSSO, P. 1999, The kidney in children with tyrosinaemia: sonographic, CT and biochemical findings. Pediatric Radiology, 29, 104–108.
   PubMed Web of Science ®Google Scholar
• FOWLER, L M., MOORE, R. B., FOSTER, J. R. and LOCK, E. A. 1991, Nephrotocodcity of 4-aminophenol glutathione conjugate. Human and Experimental Toxicology, 10, 451–459.
   PubMed Web of Science ®Google Scholar
• FOWLER, L. M., FOSTER, J. R and LOCK, E. A. 1994, Nephrotoxicity of 4-amino-3-S-glutathionylphe-nol and its modulation by metabolism or transport inhibitors. Archives of Toxicology, 68, 15-23. GANOTE, C. E., PETERSON, D. R and CARONE, F. A. 1974, The nature of D-serine-induced nephrotoxicity. American Journal of Pathology, 77, 269–282.
   Google Scholar
• GARTLAND, K P., BONNER, F. W, TIMBRELL, J. A. and NICHOLSON, J. K 1989, Biochemical characterisation of para-aminophenol-induced nephrotoxic lesions in the F344 rat. Archives of Toxicology, 63, 97–106.
   PubMed Web of Science ®Google Scholar
• GREEN, C. R., HAM, K N. and TANGE, J. D. 1969, Kidney lesions induced in rats by 4-aminophenol. British Medical Journal, i, 162–164.
   Google Scholar
• GROMPE, M., AL-DHALIMY, M., FINEGOLD, M., OU, C. N., BURLINGAME, T, KENNAWAY, N. G and SORIANO, P. 1993, Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes and Development, 7, 2298–2307.
   Google Scholar
• GROMPE, M., LINDSTEDT, S., AL-DHALIMY, M., KENNAWAY, N. G, PAPACONSTANTINOU, J., TORRES-RAMOS, C. A., Ou, C.-N. and FINEGOID, M. 1995, Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditiary tyrosinaemia type 1. Nature Genetics, 10, 453–460.
   Google Scholar
• HARRIS, R A., YANG, A., STEIN, R. C., LUCY, K, BRUSTEN, L., HERATH, A., PAREKH, R., WATERFIELD, M. D., O'HARE, M. J., NEVILLE, M. A., PAGE, M. J. and ZVELEBIL, M. J. 2002, Cluster analysis of an extensive human breast cancer cell line protein expression map database. Proteomics, 2, 212–223.
   Google Scholar
• IMAI, K., FUKUSHIMA, T, SANTA, T., HOMMA, H., HUANG, Y, SHIRAO, M. and MIURA, K. 1998, Whole body autoradiographic study on the distribution of "C-D-serine administered intravenously to rats. Amino Acids, 15, 351–361.
   PubMed Web of Science ®Google Scholar
• JORQTJERA, R. and TANGTJAY, R. M. 1999, Cyclin B-dependent kinase and caspase-1 activation precedes mitochondrial dysfunction in fumarylacetoacetate-induced apoptosis. FASEB Journal, 13, 2284–2298.
   PubMed Web of Science ®Google Scholar
• KALTENBACH, J. P., CARONE, F. A. and GANOTE, C. E. 1982, Renal tubular necrosis induced by compounds structurally related to D-serine. Experimental and Molecular Pathology, 37, 225–234.
   PubMed Web of Science ®Google Scholar
• KELSEY, G., RUPPERT, S., BEERMANN, F., GRUND, C., TANGUAY, R. M. and SCHUTZ, G. 1993, Rescue of mice homozygous for lethal albino deletions: implications for an animal model for the human liver disease tyrosinaemia type 1. Genes and Development, 7, 2285–2297.
   PubMed Web of Science ®Google Scholar
• KENNEDY, S. 2001, Proteomic profiling from human samples: the body fluid alternative. Toxicology Letters, 120, 379–384.
   PubMed Web of Science ®Google Scholar
• KENNEDY, S. 2002, The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis. Biomarkers, 7, 1–22.
   PubMed Web of Science ®Google Scholar
• KUBO, S., SUN, M., MIYAHARA, M., UMEYAMA, K, URAKAMI, K, YAMAMOTO, T., JAKOBS, C., MATSUDA, I. and ENDO, F. 1998, Hepatocyte injury in tyrosinaemia type 1 is induced by fumarylacetoacetate and is inhibited by caspase inhibitors. Proceedings of the National Academy of Sciences of the USA, 95, 9552–9557.
   PubMed Web of Science ®Google Scholar
• KYINGEN, E. A., TALsEru, T., HALVORSEN, S., JAKOBS, C., HOVIG, T. and FLATMARK, A. 1991, Renal failure in adult patients with hereditary tyrosinaemia type I. Journal of Inherited Metabolic Disease, 14, 53–62.
   PubMed Web of Science ®Google Scholar
• LABELLE, Y, PHANEUF, D. and TANGUAY, R. M. 1991, Cloning and expression analysis of a cDNA encoding fumarylacetoacetate hydrolase: post-transcriptional modulation in rat liver and kidney. Gene, 104, 197–202.
   PubMed Web of Science ®Google Scholar
• LTNDSTEDT, S., HOT-ME, E., LocK, E. A., HJAIMARSON, 0. and STRANDVIK, B. 1992, Treatment of hereditary tyrosinaemia type 1 by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet, 340, 813–817.
   Google Scholar
• NEWTON, J. F., YOSHIMOTO, M., BERNSTEIN, J., RUSH, G. F. and HooK, J. B. 1983, Acetaminophen nephrotoxicity in the rat — II. Strain differences in nephrotoxicity and metabolism of p-aminophenol, a metabolite of acetaminophen. Toxicology and Applied Pharmacology, 69, 307–318.
   PubMed Web of Science ®Google Scholar
• PAGE, M. J., AMESS, B., TOWNSEND, R. R., PAREKH, R., HERATH, A., BRUSTEN, L., ZVET-EBIL, M. J., STEIN, R C., WATERFIET-D, M. D., DAVIES, S. C. and O'HARE, M. J. 1999, Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proceedings of the National Academy of Sciences of the USA, 96, 12589–12594.
   Google Scholar
• RUPPERT, S., KELSEY, G., SCHEIDT-, A., Sul-1mm, E., THIES, E. and ScHu-rz, G. 1992, Deficiency of an enzyme of tyrosine metabolism underlies altered gene expression in newborn liver of lethal albino mice. Genes and Development, 6, 1430–1443.
   Google Scholar
• SILBERNAGI-, S., VOLKER, K. and DANTZT-ER, W. H. 1999, D-Serine is reabsorbed in rat renal pars recta. American Journal of Physiology, 276, F857—F863.
   Google Scholar
• SNUM, L. L. 2001, Key challenges for toxicologists in the 21st century. Trends in Pharmacological Sciences, 22, 281–285.
   PubMed Web of Science ®Google Scholar
• STEINER, S., ATCHER, L., RAYMACKERS, J., MEHEUS, L., ESQUER-BEASCO, R, ANDERSON, N. L. and CORDIER, A. 1996, Cyclosporine A decreases the protein level of the calcium binding protein calbindin-D 28 kDa in rat kidney. Biochemical Pharmacology, 51, 253–258.
   Google Scholar
• SUN, M. S., HAT-rom, S., Kuso, S., AWATA, H., MATSUDA, I. and ENDO, F. 2000, A mouse model of renal tubular injury of tyrosinaemia type 1: development of de Toni Fanconi syndrome and apoptosis of renal tubular cells in Fah/Hpd double mutant mice. Journal of the American Society of Nephrology, 11, 291–300.
   Google Scholar
• WIRZMANN, F. A., FULTZ, C. D, GRANT, R A., WRIGHT, L. S., KORNGUTH, S. E. and SIEGEL, F. L. 1999, Regional protein alterations in rat kidneys induced by lead exposure. Electrophoresis, 20, 943–951.
   PubMed Web of Science ®Google Scholar
• WYSS, P. A., BOYNTON, S. B., CHu, J., SPENCER, R. F. and Rom, K S. 1992, Physiological basis for an animal model of the renal Fanconi syndrome: use of succinylacetone in the rat. Clinical Science, 83, 81–87.
   PubMed Web of Science ®Google Scholar
• ZHANG, J., HERMAN, E. H., KNAPTON, A., CHADWICK, D. P., WHITEHURST, V. E., KOERNER, J. E., PAPOTAN, T, FERRANS, V. J. and SISTARE, F D. 2002, SK&F 95654-induced acute cardiovascular toxicity in Sprague-Dawley rats — histopathologic, electron microscopic, and immunohistochem-ical studies. Toxicological Pathology, 30, 28–40.
   PubMed Web of Science ®Google Scholar